Literature DB >> 19756523

Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.

Sudhakar Selvaraj1, Naga Venkatesha Murthy, Zubin Bhagwagar, Subrata K Bose, Rainer Hinz, Paul M Grasby, Philip J Cowen.   

Abstract

BACKGROUND: The serotonin transporter (5-HTT) plays a critical role in the regulation of serotonin neurotransmission and has been implicated in the pathophysiology of major depression. In a previous positron emission tomography study, we found no difference in brain 5-HTT binding between unmedicated recovered depressed patients and healthy controls. AIM: This study aims to assess brain 5-HTT binding in a group of unmedicated acutely depressed patients in comparison to healthy controls.
METHODS: We studied 5-HTT binding using [(11)C]DASB in conjunction with positron emission tomography in 12 medication-free depressed patients with a mean duration of illness of about 1 year and 24 healthy controls.
RESULTS: The depressed patients had lowered 5-HTT binding in several brain regions including brain stem, thalamus, caudate, putamen, anterior cingulate cortex and frontal cortex.
CONCLUSIONS: These results suggest that diminished availability of the 5-HTT in the brain may be a state marker of acute depression. Alternatively, low 5-HTT binding may delineate a group of depressed patients with a poor long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756523     DOI: 10.1007/s00213-009-1660-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.

Authors:  Dara M Cannon; Masanori Ichise; Denise Rollis; Jacqueline M Klaver; Shilpa K Gandhi; Dennis S Charney; Husseini K Manji; Wayne C Drevets
Journal:  Biol Psychiatry       Date:  2007-08-02       Impact factor: 13.382

Review 2.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

3.  Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652.

Authors:  Tetsuya Ichimiya; Tetsuya Suhara; Yasuhiko Sudo; Yoshiro Okubo; Kazuhiko Nakayama; Masahiro Nankai; Makoto Inoue; Fumihiko Yasuno; Akihiro Takano; Jun Maeda; Haruo Shibuya
Journal:  Biol Psychiatry       Date:  2002-05-01       Impact factor: 13.382

4.  Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.

Authors:  A A Wilson; N Ginovart; M Schmidt; J H Meyer; P G Threlkeld; S Houle
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

5.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

6.  Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents.

Authors:  M Dahlström; A Ahonen; H Ebeling; P Torniainen; J Heikkilä; I Moilanen
Journal:  Mol Psychiatry       Date:  2000-09       Impact factor: 15.992

7.  SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

Authors:  M Laruelle; R M Baldwin; R T Malison; Y Zea-Ponce; S S Zoghbi; M S al-Tikriti; E H Sybirska; R C Zimmermann; G Wisniewski; J L Neumeyer
Journal:  Synapse       Date:  1993-04       Impact factor: 2.562

8.  Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography.

Authors:  Maria A Oquendo; Ramin S Hastings; Yung-Yu Huang; Norman Simpson; R Todd Ogden; Xian-Zhang Hu; David Goldman; Victoria Arango; Ronald L Van Heertum; J John Mann; Ramin V Parsey
Journal:  Arch Gen Psychiatry       Date:  2007-02

9.  Seasonal variation in human brain serotonin transporter binding.

Authors:  Nicole Praschak-Rieder; Matthaeus Willeit; Alan A Wilson; Sylvain Houle; Jeffrey H Meyer
Journal:  Arch Gen Psychiatry       Date:  2008-09

10.  Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.

Authors:  M Reimold; A Batra; A Knobel; M N Smolka; A Zimmer; K Mann; C Solbach; G Reischl; F Schwärzler; G Gründer; H-J Machulla; R Bares; A Heinz
Journal:  Mol Psychiatry       Date:  2008-02-12       Impact factor: 15.992

View more
  18 in total

1.  Serotonin revisited.

Authors:  Philip J Cowen; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

2.  Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Beata Legutko; Lavanya Challagundla; Michael Griswold; Paul R Albert; Mireille Daigle; Jose J Miguel-Hidalgo; Mark C Austin; Randy D Blakely; David C Steffens; Craig A Stockmeier
Journal:  Neuroscience       Date:  2017-07-13       Impact factor: 3.590

3.  Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Authors:  Santhanalakshmi Sundaramurthy; Balasubramaniam Annamalai; Devadoss J Samuvel; Toni S Shippenberg; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Neuropharmacology       Date:  2016-10-12       Impact factor: 5.250

Review 4.  Affective cognition and its disruption in mood disorders.

Authors:  Rebecca Elliott; Roland Zahn; J F William Deakin; Ian M Anderson
Journal:  Neuropsychopharmacology       Date:  2010-06-23       Impact factor: 7.853

5.  A positron emission tomography study of the serotonergic system in relation to anxiety in depression.

Authors:  Zafer Iscan; Gopalkumar Rakesh; Samantha Rossano; Jie Yang; Mengru Zhang; Jeffrey Miller; Gregory M Sullivan; Priya Sharma; Matthew McClure; Maria A Oquendo; J John Mann; Ramin V Parsey; Christine DeLorenzo
Journal:  Eur Neuropsychopharmacol       Date:  2017-08-12       Impact factor: 4.600

6.  Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.

Authors:  Manesh Gopaldas; Francesca Zanderigo; Serena Zhan; R Todd Ogden; Jeffrey M Miller; Harry Rubin-Falcone; Thomas B Cooper; Maria A Oquendo; Gregory Sullivan; J John Mann; M Elizabeth Sublette
Journal:  J Affect Disord       Date:  2019-07-05       Impact factor: 4.839

7.  Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.

Authors:  Jeffrey M Miller; Natalie Hesselgrave; R Todd Ogden; Gregory M Sullivan; Maria A Oquendo; J John Mann; Ramin V Parsey
Journal:  Biol Psychiatry       Date:  2013-03-01       Impact factor: 13.382

Review 8.  Biomarkers to predict antidepressant response.

Authors:  Andrew F Leuchter; Ian A Cook; Steven P Hamilton; Katherine L Narr; Arthur Toga; Aimee M Hunter; Kym Faull; Julian Whitelegge; Anne M Andrews; Joseph Loo; Baldwin Way; Stanley F Nelson; Steven Horvath; Barry D Lebowitz
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

Review 9.  Oscillatory serotonin function in depression.

Authors:  Ronald M Salomon; Ronald L Cowan
Journal:  Synapse       Date:  2013-05-21       Impact factor: 2.562

Review 10.  Molecular, Functional, and Structural Imaging of Major Depressive Disorder.

Authors:  Kai Zhang; Yunqi Zhu; Yuankai Zhu; Shuang Wu; Hao Liu; Wei Zhang; Caiyun Xu; Hong Zhang; Takuya Hayashi; Mei Tian
Journal:  Neurosci Bull       Date:  2016-05-03       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.